Ye Wei

6.9k citations

213 papers · 4.6k indexed · 1 hit paper · h-index 36

Impact in

Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments

Papers in ⓘ

Hepatology 39
- Hepatocellular Carcinoma Treatment and Prognosis 39
Oncology 96
- Colorectal Cancer Treatments and Studies 39
- Colorectal Cancer Surgical Treatments 26
- Pancreatic and Hepatic Oncology Research 10

Co-authors: Li Ren (65 shared papers)Jianmin Xu (53 shared papers)Dexiang Zhu (61 shared papers)Xinyu Qin (24 shared papers)Guodong He (29 shared papers)Lechi Ye (15 shared papers)Jianmin Xu (35 shared papers)Meiling Ji (24 shared papers)
Journals: Journal of Clinical Oncology (18 papers)PLoS ONE (9 papers)Cancer Management and Research (6 papers)The American Journal of Surgery (5 papers)Annals of Oncology (5 papers)
Partner nations: China United States Canada

In The Last Decade

Ye Wei

201 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial 2022 · 237 citations

Peers

Countries citing papers authored by Ye Wei

Since Specialization

Citations

This map shows the geographic impact of Ye Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Wei more than expected).

Fields of papers citing papers by Ye Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Wei. The network helps show where Ye Wei may publish in the future.

Co-authors

The 25 scholars most cited alongside Ye Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ye Wei Line = papers co-authored together Ye Wei links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 213 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With KRAS Wild-Type Unresectable Colorectal Liver-Limited Metastases Journal of Clinical Oncology ·Lechi Ye, Tianshu Liu, Li Ren, Ye Wei, Dexiang Zhu, Sheng-Yong Zai, Qing‐Hai Ye, Yiyi Yu, Bo Xu, Xinyu Qin, Jianmin Xu	2013	296
2	Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial The Lancet. Gastroenterology & hepatology ·(unknown), Weitang Yuan, Taiyuan Li, Bo Tang, Baoqing Jia, Yanbing Zhou, Wei Zhang, Ren Zhao, Cheng Zhang, Longwei Cheng, Xiaoqiao Zhang, Fei Liang, Guodong He, Ye Wei, Jianmin Xu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown) Hit paper breakdown →	2022	237
3	Stromal Matrix Metalloproteinase-9 Regulates the Vascular Architecture in Neuroblastoma by Promoting Pericyte Recruitment Cancer Research ·Christophe Chantrain, Hiroyuki Shimada, Sonata Jodele, Susan Groshen, Ye Wei, David R. Shalinsky, Zena Werb, Lisa M. Coussens, Yves A. DeClerck	2004	172
4	Enhanced Recovery After Surgery (ERAS) Program Attenuates Stress and Accelerates Recovery in Patients After Radical Resection for Colorectal Cancer: A Prospective Randomized Controlled Trial World Journal of Surgery ·Li Ren, Dexiang Zhu, Ye Wei, Xiangou Pan, Li Liang, Jianmin Xu, Yunshi Zhong, Zhanggang Xue, Ling Jin, Shaokang Zhan, Weixin Niu, Xinyu Qin, Zhaohan Wu, Zhao-guang Wu	2011	170
5	Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7 OncoTargets and Therapy ·Wentao Tang, Meiling Ji, Guodong He, Liangliang Yang, Zhengchuan Niu, Mi Jian, Ye Wei, Li Ren, Jianmin Xu	2017	136
6	Prolyl Hydroxylase-3 Is Down-regulated in Colorectal Cancer Cells and Inhibits IKKβ Independent of Hydroxylase Activity Gastroenterology ·Jing Xue, Xuebing Li, Shi Jiao, Ye Wei, Guohao Wu, Jing Fang	2009	129
7	Breast Cancer: Do Specialists Make a Difference? Annals of Surgical Oncology ·Kristin A. Skinner, James T. Helsper, Dennis Deapen, Ye Wei, Richard Sposto	2003	106
8	Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer Clinical Cancer Research ·Qingyang Feng, Wenju Chang, Yihao Mao, Guodong He, Peng Zheng, Wentao Tang, Ye Wei, Li Ren, Dexiang Zhu, Meiling Ji, Yongjiu Tu, Xinyu Qin, Jianmin Xu	2019	104
9	An Aptamer-Based Biosensor for Colorimetric Detection of Escherichia coli O157:H7 PLoS ONE ·Wenhe Wu, Jie Zhang, Meiqin Zheng, Yuhong Zhong, Jie Yang, Yuhong Zhao, Wenping Wu, Ye Wei, Jie Wen, Qi Wang, Jianxin Lu	2012	103
10	Role for Sentinel Lymph Node Dissection in the Management of Large (≥5 cm) Invasive Breast Cancer Annals of Surgical Oncology ·Mathew H. Chung, Ye Wei, Armando E. Giuliano	2001	100
11	Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer Cancer Management and Research ·Yihao Mao, Qingyang Feng, Peng Zheng, Liangliang Yang, Tianyu Liu, Yuqiu Xu, Dexiang Zhu, Wenju Chang, Meiling Ji, Li Ren, Ye Wei, Guodong He, Jianmin Xu	2018	87
12	Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins The American Journal of Surgery ·Heather Macdonald, Melvin J. Silverstein, Helen Mabry, Brenda Moorthy, Ye Wei, Melinda S. Epstein, Dennis R. Holmes, Howard Silberman, Michael D. Lagios	2005	77
13	DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status Leukemia ·Brian L. Pike, Timothy C. Greiner, Xiaoming Wang, Dennis D. Weisenburger, Ya-Hsuan Hsu, Gabriel Renaud, Tyra G. Wolfsberg, Myungjin Kim, Daniel J. Weisenberger, Kimberly D. Siegmund, Ye Wei, Susan Groshen, Ruty Mehrian‐Shai, Jan Delabie, Wing C. Chan, Peter W. Laird, Joseph G. Hacia	2008	75
14	Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for RAS Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized Controlled Trial Journal of Clinical Oncology ·Wentao Tang, Li Ren, Tianshu Liu, Qing‐Hai Ye, Ye Wei, Guodong He, Qi Lin, Xiaoying Wang, Mingliang Wang, Fei Liang, Yuehong Cui, Jianmin Xu	2020	73
15	Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer The American Journal of Surgery ·Carol Woo, Howard Silberman, S Nakamura, Ye Wei, Richard Sposto, William J. Colburn, James Waisman, Melvin J. Silverstein	2002	71
16	Outcome of Patients with Colorectal Liver Metastasis: Analysis of 1,613 Consecutive Cases Annals of Surgical Oncology ·Zhu Dexiang, Li Ren, Ye Wei, Haifu Wu, Yunshi Zhong, Qing‐Hai Ye, Zhai Shenyong, Bo Xu, Li Liang, Xiangou Pan, Haohao Li, Lechi Ye, Tianshu Liu, Jia Fan, Qin Xinyu, Xu J	2012	70
17	Predictors of breast conservation therapy Cancer ·Karen Hiotis, Ye Wei, Richard Sposto, Kristin A. Skinner	2005	66
18	Genetic structure and linkage disequilibrium pattern of a rapeseed (Brassica napus L.) association mapping panel revealed by microsatellites Theoretical and Applied Genetics ·Yingjie Xiao, Dongfang Cai, Wei Yang, Ye Wei, Muhammad Younas, Jiangsheng Wu, Kede Liu	2012	64
19	Induction of autophagy by salidroside through the AMPK-mTOR pathway protects vascular endothelial cells from oxidative stress-induced apoptosis Molecular and Cellular Biochemistry ·Xiangtao Zheng, Ziheng Wu, Ye Wei, Juji Dai, Guanfeng Yu, Feng‐Lai Yuan, Lechi Ye	2016	60
20	The long non-coding RNA MALAT1 activates Nrf2 signaling to protect human umbilical vein endothelial cells from hydrogen peroxide Biochemical and Biophysical Research Communications ·Rong Zeng, Rui Zhang, Xitao Song, Leng Ni, Zhichao Lai, Changwei Liu, Ye Wei	2017	60

About Ye Wei

Ye Wei is a scholar working on Hepatology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 213 papers that have together received 4.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (39 papers), Colorectal Cancer Treatments and Studies (39 papers), Colorectal Cancer Surgical Treatments (26 papers), Gastric Cancer Management and Outcomes (19 papers), Colorectal and Anal Carcinomas (15 papers), Cancer-related molecular mechanisms research (15 papers), Lung Cancer Treatments and Mutations (13 papers) and Pancreatic and Hepatic Oncology Research (10 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.9k citations), Hepatology (535 citations), Pathology and Forensic Medicine (537 citations) and Surgery (1.2k citations). Ye Wei has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Li Ren, Jianmin Xu, Dexiang Zhu, Xinyu Qin, Guodong He, Lechi Ye, Jianmin Xu, Meiling Ji, Wenju Chang and Qing‐Hai Ye. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Cancer Management and Research, The American Journal of Surgery and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact